Eric Smith

Judge
DISC Type : Dc

Director of Translational Research, Immune Effector Cell Therapies at Dana-Farber Cancer Institute

Boston, Massachusetts, United States

Overview

Eric Smith serves as the Director of Translational Research for Immune Effector Cell Therapies at Dana-Farber Cancer Institute. An MD from the Icahn School of Medicine, he focuses on translating preclinical discoveries, especially cell-based therapies for myeloma, from the lab into clinical practice.

He is deeply engaged with the patient advocacy community, drawing inspiration from their stories to advance cell and gene therapy. Eric values scientific collaboration and mentorship, frequently crediting his colleagues and team for their collective success in research and patient care.

Dr. Smiths preclinical work has resulted in nine awarded or pending patents, with several products from his lab being translated into the clinic.

Personality Overview

Demanding

Objective Thinker

Quality Focused

They respond better to strong and respectful interactions.  They take a lot of pride in personal achievements. More than the product, they care about the impact of the product.

Topics They Care About

Cellular Therapies
His career is centered on developing and translating novel cellular therapies, such as CAR T-cells, from the lab to clinical use for cancer patients.
Translational Research
As a director in this field, his primary focus is on bridging the gap between preclinical scientific discoveries and tangible patient treatments.
Myeloma Treatment
His experience includes serving on the Myeloma Service at Memorial Sloan Kettering, and his lab's current work is focused on therapies for this disease.

Media Appearances

Eric has no verified media appearances

Work History

7-2020
Director of Translational Research, Immune Effector Cell Therapies at Dana-Farber Cancer Institute
5-2016 - 7-2020
Director of Translational Development - Cellular Therapeutics Center at Memorial Sloan Kettering Cancer Center
7-2012 - 5-2016
Medical Oncology Fellow at Memorial Sloan Kettering Cancer Center
7-2010 - 6-2012
Research Resident - Internal Medicine at The Mount Sinai Hospital

Education

2002 - 2010
MD from Icahn School of Medicine at Mount Sinai
1998 - 2002
Bachelor of Science - BS from Muhlenberg College

More Information

Social Presence :

Prographics :

Exp : 15 Location : Boston, Massachusetts, United States Job Level : Mid-senior Designation : Director of Translational Research, Immune Effector Cell Therapies at Dana-Farber Cancer Institute
URL has been copied!

Insights For Selling To Eric

During A Call Or A Meeting

DO's

  • Help them weigh the risks by sharing objective proof points without becoming too analytical
  • Use phrases like ‘it’s your decision’, ‘strategic impact’ etc.
  • Speak about competitive differentiation that your product offers

DONT's

  • Do not spend too much time focusing on product tech or features
  • Don’t be in a rush to invite them for a social meet and greet
  • Do not hesitate from asking counter questions, just avoid challenging their authority

When Cold Calling

When Writing An Email

While Negotiating & Closing

    The secret to closing fast with Eric is

  • Conviction around the impact matters the most to them, followed by a sense of achievement and ROI.
  • Will you ever get a clear answer from Eric

  • If they decide not to use your product, they will say no clearly.

Insights For Deal Planning

    How fast (or slow) will Eric move?

  • They can reach decisions fairly quickly if they are convinced.
  • Can Eric take some risk or not?

  • They don’t mind risks but can be quite binary about them.

You And Eric

Personality Compatibility


More Profiles

Discover additional public profiles from our index.

Search more profiles

Looking for someone else? Search here for anyone.

Or visit Humantic AI to know more.